日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial

生物可吸收血管支架与金属药物洗脱支架在再狭窄高风险患者中的比较:COMPARE-ABSORB试验的7年最终结果

Smits, Pieter C; Włodarczak, Adrian; Chevalier, Bernard; West, Nick E J; Gori, Tommaso; Abdel-Wahab, Mohamed; Barbato, Emanuele; Esposito, Giovanni; Tarantini, Giuseppe; Kocka, Viktor; Achenbach, Stephan; Dudek, Dariusz; Escaned, Javier; Tijssen, Jan G P; Rademaker-Havinga, Tessa A M; Serruys, Patrick; Morice, Marie-Claude; Onuma, Yoshinobu; Geuns, Robert-Jan van; Behalf Of The Compare-Absorb Trial Investigators, On

The Trial of Intraoperative Cell Salvage Versus Transfusion in Ovarian Cancer (TIC TOC): Results of a Randomized Controlled Feasibility Study

卵巢癌术中自体血液回收与输血试验(TIC TOC):一项随机对照可行性研究的结果

Galaal, Khadra; Vickery, Patricia Jane; Marques, Elsa; Palmer, Joanne; Jones, Benjamin; O'Shaughnessy, Emma; Lopes, Alberto; Ewings, Paul; Bekkers, Ruud L M; The Tic Toc Trial Group

HLA-DRB1*15:01 drives sex- and age-dependent microglial activation and neuroimmune signaling

HLA-DRB1*15:01 驱动性别和年龄依赖性的微胶质细胞活化和神经免疫信号传导

Reyes-Reyes, E M; Chinnasamy, D; Fernandez, F; Trial, M D; Nguyen, V D; He, Q; Figueroa, C; Leslie, A C; Bradford, D; Wiegand, J P; Rodgers, K E

Radiation exposure and screening yield by digital breast tomosynthesis compared to mammography: results of the TOSYMA Trial breast density related

数字乳腺断层合成与乳房 X 线摄影的辐射暴露和筛查效果比较:TOSYMA 试验结果与乳腺密度相关

Alexander Sommer, Stefanie Weigel, Hans-Werner Hense, Joachim Gerß, Veronika Weyer-Elberich, Laura Kerschke, Elke Nekolla, Horst Lenzen, Walter Heindel; TOSYMA Screening Trial Study Group

Sex Differences in Response to Diet Enriched With Glutathione Precursors in the Aging Heart

老年心脏对富含谷胱甘肽前体饮食的反应存在性别差异

Aude Angelini ,Grecia Garcia Marquez ,Anna Malovannaya ,Marta L Fiorotto ,Alexander Saltzman ,Antrix Jain ,JoAnn Trial ,George E Taffet ,Katarzyna A Cieslik

Remote ischemic conditioning for the prevention of stroke-associated pneumonia (RICA-2): protocol for a multicenter, prospective, randomized, double-blind, sham-controlled phase III trial

远程缺血预适应预防卒中相关性肺炎(RICA-2):一项多中心、前瞻性、随机、双盲、假手术对照的III期试验方案

Jia, Lina; Hou, Chengbei; Mei, Qing; Zhang, Bowei; Zhao, Wenbo; Zhao, Heng; Shang, Suhang; Guo, Xiuhai; Ma, Qingfeng; Song, Haiqing; Li, Chuanhui; Meng, Ran; Xu, Weihai; Wang, Yilong; Xu, Gelin; Wu, Chuanjie; Ji, Xunming; Investigators, For The Rica-Trial

Safety and efficacy of the DragonFly system for transcatheter valve repair of degenerative mitral regurgitation: one-year results of the DRAGONFLY-DMR trial

DragonFly系统经导管修复退行性二尖瓣反流的安全性和有效性:DRAGONFLY-DMR试验的一年结果

Wang, Jian'an; Liu, Xianbao; Pu, Zhaoxia; Chen, Mao; Fang, Zhenfei; Jin, Jun; Dong, Jianzhen; Guo, Yansong; Cheng, Biao; Xiu, Jiancheng; Luo, Jianfang; Tang, Yida; Wang, Yan; Chen, Xiaomen; Zhang, Gejun; Shao, Yibing; Song, Guangyuan; Hong, Lang; Jiang, Hong; Wu, Yangqin; Yuan, Yiqiang; Chen, Lianglong; He, Ben; Wang, Jingfeng; Xu, Kai; Yang, Yining; Zhou, Daxin; Zhang, Qi; Li, Yi; Ma, Kangmu; Lam, Yat-Yin; Han, Yaling; Ge, Junbo; Lim, D Scott; Pivotal Trial Investigators, For The Dragonflydmr

Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT Trial

急性冠脉综合征中耐久聚合物与可生物降解聚合物药物洗脱支架的比较:HOST REDUCE POLYTECH RCT试验的三年结果

Kang, Jeehoon; Hwang, Doyeon; Park, Kyung Woo; Han, Jung-Kyu; Yang, Han-Mo; Kang, Hyun-Jae; Koo, Bon-Kwon; Lim, Young-Hyo; Rhew, Jay Young; Chun, Kook Jin; Lee, Bong Ki; Kim, Sanghyun; Bae, Jang-Whan; Kim, Hyo-Soo; Host Reduce Polytech Rct Trial Investigators, On Behalf Of The

Quantitative flow ratio for the prediction of coronary events after percutaneous coronary intervention

定量血流比值用于预测经皮冠状动脉介入治疗后冠状动脉事件

Kageyama, Shigetaka; O'Leary, Neil; Chenniganahosahalli Revaiah, Pruthvi; Ninomiya, Kai; Masuda, Shinichiro; Kotoku, Nozomi; Ilancheran, Nidhi; Garg, Scot; Harte, Emma; Ni Bheolain, Grainne; Reiber, Johan H C; Tu, Shengxian; Zaman, Azfar; Sabaté, Manel; Möllmann, Helge; Sharif, Faisal; Lemoine, Julien; Wlodarczak, Adrian; Onuma, Yoshinobu; Serruys, Patrick W; Multivessel Talent Trial Investigators, On Behalf Of The

Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged

回复:由于经皮冠状动脉介入治疗在降低死亡率方面效果不显著,且手术并发症发生率较高,因此不建议对慢性完全闭塞病变进行此类治疗。

Werner, Gerald S; Hildick-Smith, David; Trial Investigators, For The EuroCTO